Location History:
- Toyonaka, JP (1984)
- Tsukuba, JP (1990 - 2001)
- Ibaraki, JP (1988 - 2003)
- Osaka, JP (2005 - 2006)
Company Filing History:
Years Active: 1984-2006
Title: **Hiroyuki Setoi: Innovator in Pharmaceutical Patents**
Introduction
Hiroyuki Setoi is a notable inventor based in Tsukuba, Japan, who has made significant contributions to the pharmaceutical industry. With 19 patents to his name, Setoi's work focuses primarily on innovative compounds that address various medical conditions.
Latest Patents
Among his latest patents, Setoi has developed **Imidazole compounds and medicinal use thereof.** This invention provides imidazole compounds represented by a general formula, which are useful in treating diseases that are managed through hypoglycemic action, as well as diseases influenced by specific actions such as cGMP-PDE inhibitory and bronchodilating actions. Additionally, he has patented **Sulfonamide compounds and uses thereof as medicines,** which involves a sulfonamide compound formula that functions effectively in prophylaxis and treatment related to similar medical actions.
Career Highlights
Hiroyuki Setoi is currently affiliated with Fujisawa Pharmaceutical Company, Ltd., where he continues to push the boundaries of pharmaceutical science. His inventions have not only expanded the available treatments but have also demonstrated potential in addressing complex health issues.
Collaborations
Setoi has collaborated with esteemed colleagues in the field, including Hirokazu Tanaka and Teruo Kyoto Oku. Their joint efforts reflect a commitment to advancing pharmaceutical development and fostering innovation through teamwork and shared expertise.
Conclusion
Through his inventive spirit and dedication to research and development, Hiroyuki Setoi stands out as a prominent figure in the pharmaceutical sector. His patents not only highlight his technical abilities but also aim to improve patient outcomes by targeting critical health challenges. As his career progresses, the medical community can anticipate further innovations from Setoi that may transform treatment methodologies.